通过辅助剂加载的冷冲击瘤细胞来加强癌症疫苗接种

Mo Chen1, Huangjuan Li2, Jing Zang3

  • 1Department of Pharmaceutical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu province, 210009, China.

Biomaterials
|September 23, 2023
PubMed
概括

一种新型的癌症疫苗使用液治疗瘤细胞 (LNT细胞) 作为抗原和辅助剂的输送载体. 与传统方法相比,这种方法提高了黑色素瘤模型中的抗瘤反应和存活率.